Springer Nature, the leading scientific journal, has issued new guidelines for using AI in research manuscripts. The corporation announced this week that software like ChatGPT couldn't be recognised as an author in studies published in its thousands of publications. However, Springer claims it has no issue with researchers employing AI to aid in writing or generating research ideas so long as the writers credit the AI appropriately.

A few papers, preprints, and scholarly articles have already been published with ChatGPT, and prior large language models (LLMs) are listed as authors. However, the kind and extent of these instruments' contributions differ from instance to situation.

The use of ChatGPT to support the usage of a specific medicine in the context of Pascal's wager is made in one opinion piece published in the journal Oncoscience, with the AI-generated content being identified. However, the sole acknowledgement of the bot's participation in a preprint paper assessing the bot's capacity to pass the United States Medical Licensing Examination (USMLE) is a statement indicating the software "contributed to the composition of various sections of this publication."

The software cannot be held responsible for publications in any meaningful way, cannot assert intellectual property rights over its work, and cannot communicate with other scientists or the media to discuss and reply to inquiries about its work.

The use of AI tools to produce a paper, even with proper attribution, needs to be clarified, even if there is widespread agreement that we should give AI authorship credit. It is partly because of issues with these tools' output that have been well-documented. For example, AI writing software has the propensity to produce "plausible bullshit," or false material presented as fact, and can reinforce societal prejudices like sexism and racism. (For an illustration, look at how CNET recently wrote articles using AI techniques. Later, more than half of those published included mistakes, according to the magazine.)